Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
06-Nov-15 Korea's Hanmi Pharmaceutical has signed a contract with Sanofi to export USD4 bn worth of diabetes treatment technology, in a deal worth almost 30% of the value of the entire Korean pharma industry. Sanofi gains an exclusive worldwide license to develop and commercialize drugs based on the materials, except in Korea and China, where Hanmi retains co-commercialization rights. [image: Business Korea]Read More
05-Nov-15 Korea's Fair Trade Commission has launched an investigation of Siemens Korea’s alleged unfair business practices in the field of medical equipment. According to the FTC, Siemens has refused to provide MRI and CT equipment software ownership and provided only the right to use the software.Read More
05-Nov-15 By utilising their budgets and borrowing funds, many hospitals in Vietnam have improved quality and raised confidence. In Hanoi 13 out of 41 public hospital and six health centres are taking part in privatisation programmes and there are 48 co-operation schemes allowing investors to invest in medical equipment. [image: VNA]Read More
05-Nov-15 China has launched a three-year pilot scheme to loosen approvals for new drugs, the country's food and drug regulator said, as Beijing looks to help stimulate innovation in the country's pharmaceutical sector. The trial will allow research and development bodies to seek drug approvals, which are currently restricted to drug manufacturers. [image: ET Healthworld]Read More
04-Nov-15 India's new government, led by Chief Minister Mufti Mohammad Sayeed, has sanctioned another 200-bed children's hospital in Bemina, Srinagar. The Union Ministry of Health and Family Welfare has also identified five districts in the state for new medical colleges, as well as two cancer institutes, in Kashmir and Jammu. Two 200-bed maternity hospitals are also in the pipeline. [image: Abid Bhat]Read More
GGM is a research and advisory firm helping clients grow profitably in international markets.
We believe the only way to understand a market properly is on the ground. Intelligence from our in-country consultants gives you a competitive advantage in China, Asia, Latin America, the Middle East, Africa and other opportunity areas.
Our clients benefit from accurate data, reliable insights and strategic advice, giving them the confidence to make better business decisions and succeed in their global growth markets.
Enter your work email to receive our free GROW newsletter on international market intelligence and strategy.
Successful track record in your sector since 1992
In-country research consultants in over 40 markets
Value for money - quality results at affordable rates
Work led by senior directors with >20 years experience
Proven frameworks for data analysis and strategy
Pragmatic advice based on accurate data and reliable insights
Get in touch to discuss your growth markets research and advisory needs: